Ainos Confirms Initial Order of 1,400 AI Nose Systems
Ainos issued a letter from Chairman, President and CEO Eddy Tsai, which read in part, "I'm proud to share that the AI Nose platform is transitioning from validation-stage pilots into structured industrial deployment. The confirmed initial order of 1,400 AI Nose systems activates recurring subscription revenue under a three-year service structure totaling approximately $2.1 million. This milestone marks our progression from proof-of-concept validation to revenue-generating implementation within semiconductor manufacturing environments. This also reflects our vision to expand AI Nose from healthcare into the broader industrial market. The broader roadmap contemplates phased deployment of up to 20,000 AI Nose systems across customer facilities. If fully executed over time, this framework could support annual order values approaching $10 million. Advancement into subsequent phases remains subject to staged technical validation and formal contractual conversion with our customer...In parallel, AI Nose is undergoing validation testing within advanced semiconductor front-end fabrication facilities - among the most technically demanding industrial environments in the world. These evaluations will set the foundation for commercial integration in advanced wafer fabrication facilities. Successful validation would expand our industrial integration opportunities within capital-intensive wafer fabrication environments. We remain focused on disciplined execution, subscription activation, and scalable infrastructure expansion as we position scent as the next AI token - advancing the smell language model (SLM), strengthening Smell ID libraries, and building SmellTech, powered by AI Nose, as a foundational sensing infrastructure for industrial AI systems."
Trade with 70% Backtested Accuracy
Analyst Views on AIMD
About AIMD
About the author

- Earnings Beat: F5, Inc. reported Q1 earnings of $4.45 per share, exceeding analyst expectations of $3.65 by 21.88%, indicating a significant improvement in profitability that is likely to positively impact stock prices.
- Revenue Growth: The quarterly revenue reached $822.47 million, surpassing the Street estimate of $758.08 million, demonstrating enhanced competitiveness in the market that may attract more investor interest.
- Optimistic Outlook: The company provided second-quarter sales guidance above estimates and raised its FY26 guidance, reflecting management's confidence in future growth, which could further drive stock price increases.
- Positive Stock Reaction: F5 shares jumped 10.9% to $299.99 in pre-market trading, indicating strong market response to its earnings report, which may draw in more investors and bolster market confidence.
Financial Performance: Ainos reported a net loss of $4.08 million for Q2 2025, with operating expenses rising 24% year-over-year and cash reserves declining by 68.6%, despite generating its first commercial revenue from the AI Nose platform.
Strategic Developments: The company is transitioning to early-stage commercial deployment, focusing on expanding its AI Nose technology and advancing VELDONA therapies through clinical trials, while securing partnerships to enhance distribution and production capabilities.
U.S. Stock Market Performance: U.S. stocks rose mid-week, with the Nasdaq Composite up 1%, while the Dow and S&P 500 also saw gains. Consumer staples performed well, but health care stocks declined.
Company Earnings Highlights: Uber reported strong second-quarter results, exceeding revenue expectations. In contrast, several companies like Fractyl Health and LifeMD faced significant stock drops due to disappointing earnings or guidance.
Market Performance: U.S. stocks saw modest gains with the Nasdaq Composite up 0.2%, while McDonald's reported better-than-expected quarterly earnings, boosting its stock price.
Sector Movements: Energy shares rose by 0.8%, whereas utilities fell by 0.8%. In commodities, oil prices increased by 1.7%, while gold and silver experienced slight declines.
Upcoming Stock Splits: Several companies, including Ainos, Helius Medical Technologies, APi Group, Channel Therapeutics, and SciSparc, are implementing stock splits or reverse stock splits between June 30 and July 4 to either boost share prices or make stocks more accessible to investors.
Purpose of Stock Splits: Stock splits increase the number of shares while maintaining market value, making stocks more affordable, whereas reverse splits reduce share count to meet exchange requirements and avoid delisting.

Collaboration Announcement: Ainos, Inc. has partnered with Advanced Semiconductor Engineering (ASE) to integrate its AI-powered scent digitization technology, known as AI Nose, into semiconductor manufacturing, aiming to enhance process efficiency, environmental safety, and compliance with ESG regulations.
Technological Advancements: The AI Nose technology will enable real-time monitoring of airborne chemicals, predictive maintenance, and improved manufacturing precision, ultimately contributing to smarter and more sustainable factory operations.








